Literature DB >> 9396907

Peripartum cardiomyopathy: a longitudinal echocardiographic study.

A G Witlin1, W C Mabie, B M Sibai.   

Abstract

OBJECTIVE: Our purpose was to determine echocardiographic trends after initial diagnosis of peripartum cardiomyopathy. STUDY
DESIGN: Nine women diagnosed with peripartum cardiomyopathy were prospectively recruited for a longitudinal echocardiographic study. Severe myocardial dysfunction was defined as left ventricular end-diastolic dimension > or = 60 mm + fractional shortening < or = 21%, and mild dysfunction was defined as left ventricular end-diastolic dimension < 60 mm + fractional shortening 22% to 24%. Unpaired t tests were used to compare sample means and Fisher's exact test used to compare discrete variables.
RESULTS: All women were seen initially for pulmonary edema. Echocardiography showed decreased systolic function in all women. The mean age at diagnosis was 33.0 +/- 6.9 years. All but one woman had a diagnosis of either chronic hypertension (n = 6) or preeclampsia (n = 2). Four women were first seen ante partum and five post partum (range 1 day to 2 months). Repeat echocardiography was performed in all nine women (median 8 months, range 6 weeks to 5 years). There was no correlation between antepartum or postpartum presentation and cardiovascular status on follow-up (p = 0.3). Values for initial left ventricular end-diastolic dimension, severe versus mild dysfunction (68.3 +/- 7.2 mm vs 55.0 +/- 4.2 mm, p = 0.046), follow-up left ventricular end-diastolic dimension, severe versus mild (68.7 +/- 4.1 mm vs 52.0 +/- 5.7 mm, p = 0.002), and follow-up fractional shortening, severe versus mild (14.6% +/- 5.0% vs 28.5% +/- 9.2%, p = 0.02) are significant. Six of the seven women with severe dysfunction had stable disease in follow-up and one is awaiting heart transplant. One of the two women with mild dysfunction had disease resolution and one had stable disease.
CONCLUSION: Patients with severe myocardial dysfunction due to peripartum cardiomyopathy are unlikely to regain normal cardiac function on follow-up.

Entities:  

Mesh:

Year:  1997        PMID: 9396907     DOI: 10.1016/s0002-9378(97)70028-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

Review 1.  The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.

Authors:  Natalie Bello; Iliana S Hurtado Rendon; Zoltan Arany
Journal:  J Am Coll Cardiol       Date:  2013-09-04       Impact factor: 24.094

2.  Echocardiography predicts adverse cardiac remodelling in heart failure.

Authors:  Hanumanth K Reddy; Santhosh Kg Koshy; Sanjeev Wasson; Kul B Aggarwal; Lokesh Tejwani; Alexander V Ovechkin; Suresh C Tyagi
Journal:  Exp Clin Cardiol       Date:  2004

Review 3.  Peripartum cardiomyopathy: a current review.

Authors:  Katie M Twomley; Gretchen L Wells
Journal:  J Pregnancy       Date:  2010-07-18

4.  Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.

Authors:  Arash Haghikia; Edith Podewski; Dominik Berliner; Kristina Sonnenschein; Dieter Fischer; Christiane E Angermann; Michael Böhm; Philipp Röntgen; Johann Bauersachs; Denise Hilfiker-Kleiner
Journal:  Clin Res Cardiol       Date:  2015-05-31       Impact factor: 5.460

5.  Role of imaging in the detection of reversible cardiomyopathy.

Authors:  Jae-Hyeong Park; Deborah H Kwon; Randall C Starling; Thomas H Marwick
Journal:  J Cardiovasc Ultrasound       Date:  2013-06-26

6.  Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy.

Authors:  Ntobeko B A Ntusi; Motasim Badri; Freedom Gumedze; Karen Sliwa; Bongani M Mayosi
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.